Arcturus Therapeutics Holdings Inc. Common Stock vs. Eli Lilly & Co.
ARCT
Arcturus Therapeutics Holdings Inc. Common Stock
$10.87 +13.94%
VS LLYEli Lilly & Co.
$1417.99 +0.61%
Arcturus Therapeutics Holdings Inc. Common Stock and Eli Lilly & Co. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ARCT | LLY | |
|---|---|---|
| Market Cap | $271.16 million | $1.26 trillion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| ARCT | LLY | |
|---|---|---|
| Dividend Yield | — | 0.49% |
ARCT and LLY split the dividend factors evenly.
Risk & Sentiment
| ARCT | LLY | |
|---|---|---|
| Short Interest | 0.22% | 1.29% |
ARCT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ARCT overview, ARCT financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.